Pregnancy clinical trials
Showing 101–150 of 205 active trials. Describe your situation to see which ones you may be eligible for.
- The Heartland Study
- Physiological-based Pharmacokinetics Approach to Medication Exposure During Pregnancy and Breastfeeding
- Observational Study of the Safety of Intravenous Artesunate Treatment of Pregnant Women and Their Infants
- The Impact of COVID-19 on Maternal and Neonatal Outcomes
- Clinical Follow-up of Pregnant Subjects Undergoing NIPT
- The Early and Late Contribution of Fasting and Postprandial Triglycerides on Newborn Subcutaneous and Intrahepatic Fat in Pregnancy
- POWERMOM, A Healthy Pregnancy Research Community
- Vitamin D Dynamics in Women
- Pregnancies Complicated by Fetal Anomalies
- Effects of High Altitude on AMPK Activation
- Healthy Start: Exploring the Fuel-mediated Programming of Neonatal Growth
- Study of Placental Function in Healthy and Pathological Pregnancies
- National Pregnancy Registry for Psychiatric Medications
- Maternal Newborn Health Registry
- Cardiometabolic Disease and Substrate Metabolism
- Remote Fetal Monitoring in High Risk Pregnancies
- Relationship Between Aspirin Metabolism and Markers of Metabolic Dysfunction Among Pregnant Persons at Risk of Pre-eclampsia
- Multi-Omics for Maternal Health After Preeclampsia
- Odevixibat Pregnancy and Lactation Surveillance Program: A Study to Evaluate the Safety of Odevixibat During Pregnancy and/or Lactation
- Pregnant Women With and Without Crohns Disease to Explore the Role of Plastics and Toxins in Intestinal Inflammation
- PRospective Evaluation of Peripartum Anticoagulation ManaGement for ThrOmboembolism
- Relugolix Pregnancy Registry: An Observational Study of the Safety of Relugolix-Containing Therapy Exposure in Pregnant Women and Their Offspring
- A Repository to Study Host-Microbiome Interactions in Health and Disease
- Examining Digital Health Care Delivery Models Through Medicaid Collaborative
- UCLA Perinatal Biospecimen Repository
- Early Tracking of Childhood Health Determinants (ETCHED) Study
- Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When Administered to Pregnant People.
- The ADVANCE (Assay Development and Validation for Pre-Natal and Obstetric Conditions) Study is the Largest U.S.-Based Prospective Study Demonstrating a Circulating Fetal Cell (CFC) Based Approach to Non-invasive Fetal Risk Assessment
- Maternal Intake of Eggs and Infant Neurodevelopment
- Impact of Lactation Antenatal Teaching by Clinicians and Healthcare Providers
- Feasibility of an ADAPTive Intervention to Improve Food Security and Maternal-Child Health
- Partnering With Antenatal Navigators to Transform Health in Pregnancy
- Leg Heating in Pregnant Women With Obesity
- Melanated Group Midwifery Care (MGMC)
- Optimizing Timing of Cesarean Delivery Consent on Labor and Delivery
- Baby Steps to Care
- Gastric Emptying of Water and Sports Drink in Labor
- Enriched Holistic Care to Eradicate Disparities in Maternal Morbidity
- Prenatal Study in Healthy Pregnant Women
- Investigating Baby Behavior and Family Technology Use Study
- The Role of Mobile Apps in Promoting Cardiovascular Health and Motivation to Exercise During Pregnancy
- Implementation of a Patient-centered, Reproductive Planning Decision Support Tool (MyPath) Among Women With Substance Use Disorder in the Immediate Postpartum Period
- Perelel Prenatal Supplements vs. Generic Prenatal Supplements and Health of Mother and Baby (SUPPORT)
- Family Foundations for Individuals Pregnant Via ART
- Mitigating Response to Stressors in Pregnant Women
- Impact of Medjool Date Consumption on Labor and Delivery Outcomes
- Impact of Room Light on Uterine Contractions and Labor Progression in Pregnancy
- Effects of Systematic Cervical Exam Training on Labor and Delivery Care
- Can Conventional ECG Technology Capture Fetal Cardiac Activity?
- Building TrUst and UNiting Teams Through DouLa partnErship - BUNDLE
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.